novo nordisk oral semaglutide fda approval The medical, cultural, economic and symbolic controversies that come with GLP-1's will continue. https://medcitynews.com/2025/12/novo-nordisk -wegovy-pill-fda-approved-oral-glp-1-drug-obesity-weight-loss-nvo Novo Nordisk wins EU approval

Novo Nordisk recommends injecting semaglutide once weekly, on the same day each week, with or without meals. Each brand pen uses 32G 4mm needles

All of that is missing from this picture.

High-street pharmacies such as Boots can dispense GLP-1 medications, but do not typically conduct the clinical consultation themselves

Data Availability Data sharing is not applicable in this article as no datasets were generated or analyzed during the current study

ICYMI, GLP-1 has become a very buzzy word in weight management discourse over the past couple of years, so its worth giving a brief explanation of exactly what it is

Wang YS, Liang SS, Ren JJ, et al